News Hologic, Inc.

Equities

HOLX

US4364401012

Real-time Estimate Cboe BZX Other stock markets 12:18:56 2024-05-07 pm EDT			5-day change	1st Jan Change
75.9 ^USD	-0.04%		+0.45%	+6.52%

May. 06	Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	MT
May. 03	JPMorgan Adjusts Price Target on Hologic to $91 From $85	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	May. 05	MT
JPMorgan Adjusts Price Target on Hologic to $91 From $85	May. 03	MT
UBS Adjusts Price Target on Hologic to $81 From $79, Maintains Neutral Rating	May. 03	MT
Hologic : Second Quarter Fiscal 2024 Earnings Conference Call Transcript	May. 03	PU
Hologic : Second Quarter 2024 Transcript	May. 03	PU
Hologic : Second Quarter 2024 Prepared Remarks	May. 02	PU
Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours	May. 02	MT
Transcript : Hologic, Inc., Q2 2024 Earnings Call, May 02, 2024	May. 02
Hologic: Fiscal Q2 Earnings Snapshot	May. 02	AQ
Earnings Flash (HOLX) HOLOGIC Posts Q2 EPS $1.03, vs. Street Est of $0.98	May. 02	MT
Earnings Flash (HOLX) HOLOGIC Reports Q2 Revenue $1.02B, vs. Street Est of $1B	May. 02	MT
(HOLX) HOLOGIC Expects Fiscal Year 2024 EPS Range $4.02 - $4.12	May. 02	MT
(HOLX) HOLOGIC Sees Q3 EPS Range $0.98 - $1.05	May. 02	MT
Hologic Announces Financial Results for Second Quarter of Fiscal 2024	May. 02	BU
Hologic, Inc. Reports Impairment of Intangible Assets for the Second Quarter Ended March 30, 2024	May. 02	CI
Hologic, Inc. Revises Earnings Guidance for the Fiscal Year 2024	May. 02	CI
Hologic, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024	May. 02	CI
Hologic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 30, 2024	May. 02	CI
Hologic : Statement on USPSTF Final Breast Cancer Screening Guidelines	Apr. 30	PU
Molten Ventures portfolio firm gets bought by Hologic	Apr. 30	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hologic, Inc.

Equities

HOLX

US4364401012

Summary

Filters